Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
5.22
+0.15 (2.96%)
At close: Nov 5, 2024, 4:00 PM
5.16
-0.06 (-1.15%)
After-hours: Nov 5, 2024, 6:35 PM EST

Humacyte Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Market Capitalization
653294218747131-
Market Cap Growth
93.27%35.19%-70.86%471.21%--
Enterprise Value
5782519754939-
Last Close Price
5.222.842.117.2510.17-
PE Ratio
--2.65-18.17-10.94-0.88-
PS Ratio
--139.03591.2787.68-
PB Ratio
-20.2121.721.866.111.85-
P/FCF Ratio
-6.98-3.89-3.01-9.17-2.34-
P/OCF Ratio
-7.08-4.01-3.06-9.20-2.35-
EV/Sales Ratio
--61.82434.3125.88-
EV/EBITDA Ratio
-5.35-2.81-1.27-7.52-0.69-
EV/EBIT Ratio
-4.98-2.59-1.14-6.75-0.60-
EV/FCF Ratio
-6.50-3.32-1.34-6.74-0.69-
Debt / Equity Ratio
-0.674.290.430.420.410.21
Debt / FCF Ratio
-0.23-0.77-0.70-0.63-0.52-0.34
Asset Turnover
--0.010.010.01-
Quick Ratio
5.274.367.7620.423.568.70
Current Ratio
5.414.527.8820.753.698.76
Return on Equity (ROE)
-850.81%-169.81%-10.01%-27.46%-65.58%-
Return on Assets (ROA)
-43.61%-36.44%-21.54%-25.81%-29.32%-
Return on Capital (ROIC)
-123.55%-50.64%-31.01%-37.20%-31.18%-
Earnings Yield
-21.40%-37.66%-5.50%-3.55%-50.88%-
FCF Yield
-12.55%-25.70%-33.17%-10.90%-42.75%-
Buyback Yield / Dilution
-5.25%-0.36%-157.82%-593.25%71.34%-
Total Shareholder Return
-5.25%-0.36%-157.82%-593.25%71.34%-
Source: S&P Capital IQ. Standard template. Financial Sources.